Risk factor
Limited trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Headquartered in Johannesburg, South Africa, Life Healthcare Group Holdings Limited, established in 1983, operates as a prominent international provider of private hospital services. Its extensive operations span South Africa, Canada, the United Kingdom, various other European countries, and broader international markets. The company's business is structured into two principal divisions: Hospitals and Complementary Services, and Healthcare Services. It delivers a comprehensive range of acute hospital care alongside diverse complementary offerings. These include the specialized services of Life Esidimeni, which covers chronic mental healthcare, frail care, rehabilitation, step-down facilities, correctional healthcare, primary care, and substance abuse recovery programs. Additionally, its Life Employee Health Solutions segment provides on-site occupational health, primary healthcare, and employee wellness initiatives. The company's medical expertise extends across numerous fields, such as diagnostics, mental health treatment, acute rehabilitation, renal dialysis, oncology, cardiology, neurology, orthopedics, pediatrics, dermatology, ophthalmology, gynecology, and obstetrics. Furthermore, Life Healthcare is involved in advanced diagnostic imaging, operating magnetic resonance imaging (MRI) and computerized tomography (CT) scanners, and both developing and distributing radiopharmaceuticals vital for positron emission tomography-computerized tomography (PET-CT) diagnostics. The organization was formerly known as Afrox Healthcare Limited until its name change to Life Healthcare Group Holdings Limited in January 2005.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap'
Target Price
The average target price of LHC.JO is 1365 and suggests 34% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr